Where does Orion Biotech Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Orion Biotech Inc. ranks #49,379 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Orion Biotech Inc. hold?

Orion Biotech Inc. holds 5 US utility patents granted between 2020 and 2022, spanning 8 technology areas.

What is Orion Biotech Inc.'s Innovation Score?

Orion Biotech Inc. has an Innovation Score of 26.0 out of 100 (19th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Orion Biotech Inc. focus on?

Orion Biotech Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 3 patents. Grants appear in 8 CPC subclasses total.

Is Orion Biotech Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Orion Biotech Inc..

What does claim depth mean for Orion Biotech Inc.'s patents?

Orion Biotech Inc.'s patents average 9.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Orion Biotech Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Orion Biotech Inc.

USPTO PatentsView assignee record - 5 granted patents across 8 technology areas, recorded in grant years 2020–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Orion ranks #49,379 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 8 technology areas.

#49,379
of 49,997 US assignees by volume: 19th percentile
by Innovation Score (26.0/100): 9.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R49379 · Foreign Corporation #49,379 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #49,379/49,997
PHOTO-FINISH Organik Kimya…
CPC-NARROW A61B · 8 areas
INNOV-THIN 26.0/100
CLAIMS-PAR 9.0 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2022 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Organik Kimya Sanayi VE TIC. A.S. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Lifeworx · near

26
Abtum · near

26
Orion Biotech · this assignee

26
Strategic Patent… · near

26
Jonnat Management · near

26
3D Lighting… · lowest

7

What this shows Orion's Innovation Score is 26.0/100 (19th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Orion's grants concentrate

Orion Biotech Inc. is a focused PatentsView assignee: 8 CPC subclasses with 60% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2020. By volume, Orion sits between Organik Kimya Sanayi VE TIC. A.S. and Ortlieb Sportarikel GMBH.

Orion's three-year grant acceleration

Orion Biotech Inc. shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Organik Kimya San…

5
Orgentec Diagnost…

5
Oribase Pharma

5
Orient Service

5
Orion Innovations

5
Orlucent

5
Orthogen

5
Ortlieb Sportarik…

5
Orion Biotech ◀

5

What this shows Orion holds 5 patents at rank #49,307, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Orion

By rank, the assignees closest to #49,307 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Orion's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Orion, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (26 here).

Abtum Inc. 26 Strategic Patent Management, LLC 26 Lifeworx, Inc. 26 Jonnat Management Corp. 26

Orion's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 19th percentile higher than 19% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Orion Biotech Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	20.0%
2021	2	40.0%
2022	2	40.0%

Which technologies does Orion Biotech Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 3

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 2

H04Q - Selecting 1

H01Q - Antennas, i.e. Radio Aerials 1

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 1

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

Top 8 of 8 technology areas

Where it ranks

Overall rank by patents

#49,379

of 49,997 tracked assignees

Innovation Score

26.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Orion Biotech Inc.'s patent record in context - here's where to go next.

Orion Biotech Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 60% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #49,379 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Orion Biotech Inc. against Organik Kimya Sanayi VE TIC. A.S., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 26.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.